NCT00254332
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Pittsubrgh Medical Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
35 public trials
8 recruiting studies
Sezary Syndrome trial results
NCT00177190
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT00748319
- Conditions
- Dermatitis, Dermatitis, Exfoliative, Disease, +18 more
- Locations
-
- Groupe hospitalier Henri Mondor - Albert Chenevier Créteil, France
NCT00050999
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
- Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
- Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia
Completed
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
NCT00051012
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
- Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
- Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia